Skip to main content
BMC is moving to Springer Nature Link. Visit this journal in its new home.
Fig. 5 | BMC Veterinary Research

Fig. 5

From: PARP inhibitor olaparib induces DNA damage and acts as a drug sensitizer in an in vitro model of canine hematopoietic cancer

Fig. 5
See More

Schematic representations of the potential of PARPi in cancer therapy. Characterization of the molecular effects of PARPi combinations with additional drugs in various cancer types as a first step to develop new, molecular-based targeted therapeutic strategies in veterinary oncology

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us